Asset Management Corp’s AbbVie ABBV Stock Holding History

Asset Management Corp’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$3.47M	Sell	21,776 -502	-2%	-$76.7K	2.72%	7
2022 Q4	$3.6M	Sell	22,278 -1,471	-6%	-$226K	3.02%	5
2022 Q3	$3.19M	Sell	23,749 -30	-0.1%	-$4.3K	1.91%	11
2022 Q2	$3.64M	Buy	23,779 +79	+0.3%	+$12.1K	2.35%	8
2022 Q1	$3.84M	Sell	23,700 -921	-4%	-$134K	1.92%	8
2021 Q4	$3.33M	Sell	24,621 -348	-1%	-$41.1K	1.65%	10
2021 Q3	$2.69M	Buy	24,969 +4,750	+23%	+$543K	1.35%	14
2021 Q2	$2.28M	Sell	20,219 -335	-2%	-$37.7K	1.31%	19
2021 Q1	$2.22K	Sell	20,554 -524	-2%	-$56K	0.95%	22
2020 Q4	$2.33M	Sell	21,078 -1,872	-8%	-$180K	1.3%	17
2020 Q3	$2.01M	Sell	22,950 -111	-0.5%	-$10.4K	1.22%	13
2020 Q2	$2.26M	Sell	23,061 -550	-2%	-$48.4K	1.44%	12
2020 Q1	$1.8M	Sell	23,611 -720	-3%	-$61.3K	1.61%	10
2019 Q4	$2.15M	Buy	+24,331	New	+$2.02M	1.52%	10

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Asset Management Corp's ABBV Position: Q1 2023 in Review

Asset Management Corp reduced its AbbVie (ABBV) stake by 2.3% in Q1 2023, selling an estimated $76.7K and leaving 21,776 shares worth $3.47M. The position accounts for 2.72% of the portfolio, ranked #7.

Asset Management Corp first reported a position in ABBV in Q4 2019 and has held it in 14 quarters since. The position peaked at $3.84M in Q1 2022. 3,139 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

Asset Management Corp held 21,776 shares of AbbVie worth $3.47M as of Q1 2023.
Asset Management Corp sold 502 AbbVie shares in Q1 2023, an estimated $76.7K.
AbbVie made up 2.72% of Asset Management Corp's portfolio in Q1 2023, its #7 holding.
Asset Management Corp first reported a position in AbbVie in Q4 2019 and has held it in 14 quarters since.
Asset Management Corp's AbbVie position peaked at $3.84M in Q1 2022.
3,139 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Asset Management Corp's 13F filing for Q1 2023, filed 14 Apr 2023.